Phase II/III randomized immunogenicity and safety study of a Brazilian meningococcal serogroup B vaccine in children.
Saved in:
| Title: | Phase II/III randomized immunogenicity and safety study of a Brazilian meningococcal serogroup B vaccine in children. |
|---|---|
| Authors: | Martins RM; Bio-Manguinhos/Fiocruz, Rio de Janeiro, Brazil., Maia MLS; Clinical Advisory Unit, Bio-Manguinhos/Fiocruz, Brazil., Camacho LAB; National School of Public Health, Fiocruz, Brazil., Noronha TG; Clinical Advisory Unit, Bio-Manguinhos/Fiocruz, Brazil., von Doellinger VR; Clinical Advisory Unit, Bio-Manguinhos/Fiocruz, Brazil., Santos AP; Bacterial Technology Laboratory, Bio-Manguinhos/Fiocruz, Brazil., Figueira ES; Bacterial Technology Laboratory, Bio-Manguinhos/Fiocruz, Brazil., Leal ML; Bacterial Technology Laboratory, Bio-Manguinhos/Fiocruz, Brazil., Jessouroun E; Bacterial Technology Laboratory, Bio-Manguinhos/Fiocruz, Brazil. Electronic address: ellen@bio.fiocruz.br. |
| Source: | Vaccine [Vaccine] 2025 Aug 13; Vol. 61, pp. 127363. Date of Electronic Publication: 2025 Jun 09. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Clinical Trial, Phase III |
| Journal Info: | Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1873-2518 |
|---|---|
| DOI: | 10.1016/j.vaccine.2025.127363 |
